EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2

Mengrui Chai, Rongrong Zhang, Linjia Guo, Hualin Liu, Mengmeng Yang, Jingru Qu, Fei Liu, Yinuo Zhai, Weili Wang, Huizhen Zheng, Fei Yan, Fuqiang Liu

Frontiers in Genetics · 19.11.2026 · 17

DOI: 10.3389/fgene.2026.1963869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 19.11.2026. Verfasst von Mengrui Chai und 11 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Familial partial lipodystrophy type 2 (FPLD2) is an autosomal dominant genetic disorder caused by mutations in the LMNA gene, characterized by the selective loss of adipose tissue, and is associated with various metabolic abnormalities. In this study, we investigated a Chinese woman diagnosed with FPLD2 to elucidate the effects of a novel intronic variant in the LMNA gene on pre-mRNA splicing. The LMNA variant c.1488 + 2T>C has been previously reported by Shchagina et al., in 2025. Here, we describe a Chinese woman with a severe FPLD2 phenotype carrying this heterozygous splice-site variant and provide functional characterization of its effects on pre-mRNA splicing.

Methods

Whole-exome sequencing (WES) was used to identify the causative variant within the family, and the identified variant was subsequently validated through Sanger sequencing. We adopted bioinformatic tools to predict the potential effect of the identified mutation on splicing. An in vitro minigene splicing assay was also performed to evaluate the effect of this novel mutation on RNA splicing, with the splicing outcomes confirmed by Sanger sequencing.

Results

A heterozygous mutation, c.1488 + 2T>C (exon 8, NM_170707), in the LMNA gene was identified in a Chinese female patient via whole-exome and Sanger sequencing. This mutation was absent in the patient’s parents. In accordance with American College of Genetic Medicine and Genomics guidelines, the variant was initially classified as uncertain significance (VUS) by applying criteria PVS1_Moderate, PM6, and PM2_Supporting. Bioinformatic analyses using BDGP, NetGene2-2.42, and RDDC indicated that the variant would likely affect splicing. Our in vitro minigene assay further confirmed that the c.1488 + 2T>C mutation in LMNA resulted in three distinct aberrant mRNA isoforms: retention of 59 bp from intron 8 (NM_170707.4: c.1488 + 1_1488 + 59ins), deletion of nine nucleotides from exon 8 (gtggtgacg; NM_170707.4: c.1480_1488del), and exon 8 skipping (NM_170707.4: c.1381_1488del). These splicing events generated three distinct protein variants: a truncated protein with a premature stop codon (p.Ile497AlafsTer70), a protein lacking three amino acids (p.Val494_Thr496del), and a protein with a partial amino acid sequence deletion (p.Asp461_Thr496del).

Conclusion

We herein identified a novel heterozygous mutation, c.1488 + 2T>C, in the LMNA gene that induced abnormal mRNA splicing. This study expands the spectrum of LMNA gene variants, enhances the clinical understanding of LMNA-related disorders, facilitates precise genetic counseling for the affected family, and offers guidance for early diagnosis and disease management. Furthermore, it validates the minigene assay as a robust method for characterizing mRNA splicing profiles.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Key Research and Development Program of China

Zitieren

APA

Chai, M., Zhang, R., Guo, L., Liu, H., Yang, M., Qu, J., Liu, F., Zhai, Y., Wang, W., Zheng, H., Yan, F., & Liu, F. (2026). Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1963869

Vancouver

Chai M, Zhang R, Guo L, Liu H, Yang M, Qu J, et al. Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1963869

BibTeX
@article{Chai2026,
  author = {Chai, Mengrui and Zhang, Rongrong and Guo, Linjia and Liu, Hualin and Yang, Mengmeng and Qu, Jingru and Liu, Fei and Zhai, Yinuo and Wang, Weili and Zheng, Huizhen and Yan, Fei and Liu, Fuqiang},
  title = {Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1963869}
}
Kostenlos starten →